Nobukazu Hayashi Selected Research

Nobukazu Hayashi Research Topics

Disease

22	Acne Vulgaris 08/2022 - 12/2004
3	Hidradenitis Suppurativa 04/2022 - 09/2019
2	Pain (Aches) 04/2022 - 09/2019
2	Eosinophilic pustular folliculitis 05/2021 - 01/2004
2	Cicatrix (Scar) 01/2020 - 10/2003
2	Pruritus (Itching) 08/2016 - 07/2014
2	Atopic Dermatitis (Atopic Eczema) 08/2016 - 07/2014
2	Seborrheic Keratosis 07/2013 - 08/2004
1	Heart Failure 04/2022
1	Infections 01/2022
1	Abscess 09/2019
1	Dermatitis 05/2018
1	Hemangioma (Angioma) 08/2017
1	Multi-centric Castleman's Disease 03/2017
1	Hypergammaglobulinemia (Hyperimmunoglobulinemia) 03/2017
1	Inflammation (Inflammations) 03/2017
1	Anemia 03/2017
1	Purpura 03/2017
1	IgA Vasculitis (Purpura, Schoenlein Henoch) 03/2017
1	Erythema elevatum diutinum 03/2017
1	Hyperhidrosis 01/2017
1	Neoplasm Metastasis (Metastasis) 09/2015
1	Melanoma (Melanoma, Malignant) 09/2015
1	Eczema 07/2014
1	Melanosis (Freckles) 07/2013
1	Lentigo (Lentiginosis) 07/2013
1	Hyperpigmentation 07/2013
1	Diarrhea 06/2012
1	Skin Diseases (Skin Disease) 07/2005
1	Nevus (Nevi) 06/2005
1	Fibrosis (Cirrhosis) 01/2005
1	Biliary Atresia 01/2005
1	Neoplasms (Cancer) 08/2004
1	Alopecia (Baldness) 07/2004
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2004

Drug/Important Bio-Agent (IBA)

4	Adapalene (Differin)FDA LinkGeneric 08/2018 - 06/2012
3	Anti-Infective Agents (Microbicides)IBA 08/2022 - 11/2017
3	Doxycycline (Periostat)FDA LinkGeneric 08/2022 - 01/2017
3	Adalimumab (Humira)FDA Link 04/2022 - 09/2019
2	Tetracycline (Achromycin)FDA LinkGeneric 08/2022 - 09/2021
2	Minocycline (Cyclops)FDA LinkGeneric 08/2022 - 02/2011
2	TetracyclinesIBA 08/2020 - 01/2017
2	Clindamycin (Cleocin)FDA LinkGeneric 08/2020 - 01/2019
2	Benzoyl Peroxide FDA LinkGeneric 08/2018 - 07/2017
2	Phosphodiesterase 4 InhibitorsIBA 08/2016 - 07/2014
2	methyl 4- (((3- (6,7- dimethoxy- 2- (methylamino)quinazolin- 4- yl)phenyl)amino)carbonyl)benzoateIBA 08/2016 - 07/2014
2	Anti-Bacterial Agents (Antibiotics)IBA 06/2012 - 02/2011
2	fropenem (faropenem)IBA 06/2012 - 02/2011
2	Connective Tissue Growth FactorIBA 06/2005 - 01/2005
2	Messenger RNA (mRNA)IBA 01/2005 - 08/2004
1	C-Reactive ProteinIBA 04/2022
1	CatecholaminesIBA 08/2021
1	NormetanephrineIBA 08/2021
1	MetanephrineIBA 08/2021
1	Amylases FDA Link 08/2021
1	MacrolidesIBA 08/2020
1	23S Ribosomal RNAIBA 01/2020
1	QuinolonesIBA 09/2019
1	Levofloxacin (Levaquin)FDA Link 09/2019
1	Pharmaceutical PreparationsIBA 08/2018
1	clindamycin phosphate (Clindets)FDA LinkGeneric 08/2018
1	RetinoidsIBA 05/2018
1	Propranolol (Inderal)FDA LinkGeneric 08/2017
1	Immunoglobulin A (IgA)IBA 03/2017
1	Immunoglobulin G (IgG)IBA 03/2017
1	Interleukin-6 (Interleukin 6)IBA 03/2017
1	tocilizumab (atlizumab)FDA Link 03/2017
1	Acyclovir (Aciclovir)FDA LinkGeneric 01/2017
1	Methylprednisolone FDA LinkGeneric 01/2017
1	Therapeutic UsesIBA 07/2014
1	Heparinoids (Heparinoid)IBA 07/2014
1	CytokinesIBA 07/2013
1	Stem Cell FactorIBA 07/2013
1	Proto-Oncogene Proteins c-kit (Proto-Oncogene Protein c-kit)IBA 07/2013
1	Endothelins (Endothelin)IBA 07/2013
1	glycolic acid (glycolate)IBA 04/2012
1	RoxithromycinIBA 02/2011
1	CosmeticsIBA 07/2005
1	Transforming Growth Factor beta (TGF-beta)IBA 06/2005
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 06/2005
1	Collagen Type IV (Type IV Collagen)IBA 01/2005
1	Indicators and Reagents (Reagents)IBA 01/2005
1	PAR-2 ReceptorIBA 08/2004
1	Proteinase-Activated ReceptorsIBA 08/2004
1	Melanins (Melanin)IBA 08/2004
1	Finasteride (Propecia)FDA LinkGeneric 07/2004
1	Dihydrotestosterone (Androstanolone)IBA 07/2004
1	Testosterone (Sustanon)FDA Link 07/2004
1	5-alpha Reductase InhibitorsIBA 07/2004
1	Indomethacin (Indometacin)FDA LinkGeneric 01/2004
1	baysilon (polydimethylsiloxane)IBA 10/2003

Therapy/Procedure

8	Therapeutics 01/2020 - 10/2003
1	Hematopoietic Stem Cell Transplantation 05/2021
1	Aftercare (After-Treatment) 01/2020
1	Surgical Amputation (Amputations) 09/2015
1	Lymph Node Excision (Lymph Node Dissection) 09/2015
1	Ambulatory Care (Outpatient Care) 12/2004
1	Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation) 01/2004
1	Conservative Treatment 10/2003
1	Dye Lasers 10/2003